Literature DB >> 28818879

Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives.

Silke Ryan1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28818879     DOI： 10.1183/13993003.01182-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.

Authors:  Katharine A Hintz; Athos J Rassias; Kathleen Wardwell; Marcia L Moss; Peter M Morganelli; Patricia A Pioli; Alice L Givan; Paul K Wallace; Mark P Yeager; Paul M Guyre
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

Review 2.  Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases.

Authors:  Christa Buechler; Kristina Eisinger; Sabrina Krautbauer
Journal:  Inflamm Allergy Drug Targets       Date:  2013-12

3.  Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma.

Authors:  Holger Jon Møller; Niels Anker Peterslund; Jonas Heilskov Graversen; Søren Kragh Moestrup
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation.

Authors:  Aoife M Murphy; Amandine Thomas; Sophie J Crinion; Brian D Kent; Murtaza M Tambuwala; Aurelie Fabre; Jean-Louis Pepin; Helen M Roche; Claire Arnaud; Silke Ryan
Journal:  Eur Respir J       Date:  2017-04-19       Impact factor: 16.671

5.  Identification of the haemoglobin scavenger receptor.

Authors:  M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3.

Authors:  N Matsushita; M Kashiwagi; R Wait; R Nagayoshi; M Nakamura; T Matsuda; P Hogger; P M Guyre; H Nagase; T Matsuyama
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

7.  Serum soluble CD163 predicts risk of type 2 diabetes in the general population.

Authors:  Holger J Møller; Ruth Frikke-Schmidt; Søren K Moestrup; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  Clin Chem       Date:  2010-11-24       Impact factor: 8.327

8.  Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.

Authors:  Anders Etzerodt; Maciej Bogdan Maniecki; Kirsten Møller; Holger Jon Møller; Søren Kragh Moestrup
Journal:  J Leukoc Biol       Date:  2010-08-31       Impact factor: 4.962

Review 9.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

10.  Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.

Authors:  Jana Kračmerová; Lenka Rossmeislová; Zuzana Kováčová; Eva Klimčáková; Jan Polák; Michaela Tencerová; Lucia Mališová; Vladimír Štich; Dominique Langin; Michaela Šiklová
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958
View more
  1 in total

1.  Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies.

Authors:  Anna Stempkowska; Magdalena Walicka; Edward Franek; Marek Naruszewicz; Mariusz Panczyk; Yarsolav Sanchak; Agnieszka Filipek
Journal:  Genes (Basel)       Date:  2020-10-24       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.